{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-033756","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.364435+00:00","generated_at":"2026-06-25T00:18:06.971876+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Protara Therapeutics CFO Blaine Davis to depart July 15, 2022","bullets":["CFO Blaine Davis leaving to pursue other opportunities, effective July 15, 2022; resignation not due to disagreements.","Separation agreement: 12-month base salary lump sum, target bonus, COBRA and life insurance premiums, accelerated equity vesting.","Company had $119M cash, cash equivalents and investments as of March 31, 2022, expected to fund operations into mid-2024.","CEO Jesse Shefferman thanked Davis for building finance, commercial, and IT functions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-033756","json":"https://secwatch.observer/filing/0001213900-22-033756.json","markdown":"https://secwatch.observer/filing/0001213900-22-033756.md","text":"https://secwatch.observer/filing/0001213900-22-033756.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022033756/0001213900-22-033756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022033756/ea161829-8k_protara.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:18:06.971876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"60d18b1dc4","claim":"Blaine Davis departed as Chief Financial Officer at Protara Therapeutics, Inc..","evidence_excerpt":"On June 21, 2022 Protara Therapeutics, Inc. (the “Company”) announced that Blaine Davis, Chief Financial Officer of the Company, will be leaving the Company to pursue other opportunities effective as of July 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022033756/0001213900-22-033756-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"leaving"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}